Wednesday, November 15, 2006

Cobalt follows DRL and Spectrum

After DRL and Spectrum, Cobalt also reached a patent lawsuit settlement with GSK regarding infringement of O.B. listed patents for Sumatriptan Succinate tablets. According to Cobalt it may distribute a generic version in the U.S. by the first quarter of 2009 following the settlement which remains subject to government review. Read also: What Glaxo Want? After DRL, its Spectrum to Settle Imitrex Patent Dispute with Glaxo

No comments:

Post a Comment